Gland Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,742.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.80 per cent from ₹1,695.36 crore. This corresponds to a year-on-year *(YoY) growth of 22.31 per cent.
Operating Profit
Operating Profit stands at ₹513.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.97 per cent from ₹410.53 crore. This corresponds to a year-on-year *(YoY) growth of 47.62 per cent.
PBDT
PBDT stands at ₹614.46 crore, reflecting a quarter-on-quarter *(QoQ) increase of 30.80 per cent from ₹469.78 crore. This corresponds to a year-on-year *(YoY) growth of 59.98 per cent.
Profit Before Tax
Profit Before Tax stands at ₹505.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 39.67 per cent from ₹362.13 crore. This corresponds to a year-on-year *(YoY) growth of 75.42 per cent.
Net Profit
Net Profit stands at ₹366.68 crore, reflecting a quarter-on-quarter *(QoQ) increase of 40.23 per cent from ₹261.48 crore. This represents a 96.57 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Gland Pharma Ltd News
Gland Pharma Ltd Earnings
- YOY
- QOQ
Gland Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gland Pharma Ltd Research Reports
Gland Pharma Ltd Financial Reports
Gland Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Gland Pharma | 5.13% | 7.58% | 9.14% | 46.61% | 45.28% | 33.32% |
| Anthem Bioscienc | 0.00% | 0.61% | 2.60% | 16.18% | 19.04% | 6.11% |
| Ipca Labs. | 1.20% | 3.14% | 11.81% | 10.64% | 17.39% | 21.84% |
| Ajanta Pharma | 0.06% | 3.88% | 15.17% | 19.80% | 22.01% | 34.90% |
| Glaxosmi. Pharma | 2.25% | 1.87% | 8.84% | 3.19% | -2.93% | -28.43% |
| J B Chemicals & | 0.35% | 3.17% | 7.58% | 14.54% | 26.50% | 39.85% |
| Emcure Pharma | -0.13% | 0.42% | 8.27% | 16.18% | 35.30% | 44.00% |
Company Info
Company Information
Chairman / Executive Director / MD / CEO : SRINIVAS SADU
Independent Non Exe. Director : UDO JAHANNES VETTER
Independent Non Exe. Director : ESSAJI GOOLAM VAHANVATI
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Independent Non Exe. Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Wenjie Zhang
Non-Exec & Non-Independent Dir : Wei Huang
CS / Compliance Officer / Vice President : SAMPATH KUMAR PALLERLAMUDI
Additional Director : William Robert Keller